Reshaping the way we view vitamin D signalling and the role of vitamin D in health

Nutrition Research Reviews

Volumn 17, Issue 2, 2004, Pages 241-248

  Fleet, James C ^a   Hong, Jie ^a   Zhang, Zhentao ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

Calcium homeostasis; Cancer prevention; Cell signalling pathways; Vitamin D

Indexed keywords

CALCITRIOL; INOSITOL PHOSPHATE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PHOSPHOLIPASE C; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; VITAMIN D; VITAMIN D RECEPTOR;

CALCIUM HOMEOSTASIS; CANCER PREVENTION; CANCER RISK; ENZYME ACTIVITY; HUMAN; REVIEW; SIGNAL TRANSDUCTION; VITAMIN D METABOLISM;

EID: 12744279624     PISSN: 09544224     EISSN: None     Source Type: Journal    
DOI: 10.1079/NRR200480     Document Type: Review

References (62)

1. Ahonen MH, Tenkanen L, Teppo L, Hakama M & Tuohimaa P (2000) Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes Control 11, 847-852.
2. Armbrecht HJ, Boltz MA, Hodam TL & Kumar VB (2001) Differential responsiveness of intestinal epithelial cells to 1,25-dihydroxyvitamin D3 - role of protein kinase C. Journal of Endocrinology 169, 145-151.
3. Baran DT, Sorensen AM, Shalhoub V, Owen T, Stein G & Lian J (1992) The rapid nongenomic actions of 1 alpha,25-dihydroxyvitamin D3 modulate the hormone-induced increments in osteocalcin gene transcription in osteoblast-like cells. Journal of Cellular Biochemistry 50, 124-129.
4. Barger-Lux MJ, Heaney RP, Lanspa SJ, Healy JC & DeLuca HF (1995) An investigation of sources of variation in calcium absorption efficiency. Journal of Clinical Endocrinology and Metabolism 80, 406-411.
5. Barletta F, Freedman LP & Christakos S (2002) Enhancement of VDR-mediated transcription by phosphorylation: correlation with increased interaction between the VDR and DRIP205, a subunit of the VDR-interacting protein coactivator complex. Molecular Endocrinology 16, 301-314.
6. Bettoun DJ, Burris TP, Houck KA, Buck DW II, Stayrook KR, Khalifa B, Lu J, Chin WW & Nagpal S (2003) Retinoid X receptor is a nonsilent major contributor to vitamin D receptor-mediated transcriptional activation. Molecular Endocrinology 17, 2320-2328.
7. Boyan BD, Dean DD, Sylvia VL & Schwartz Z (1994) Nongenomic regulation of extracellular matrix events by vitamin D metabolites. Journal of Cellular Biochemistry 56, 331-339.
8. Boyan BD, Dean DD, Sylvia VL & Schwartz Z (2003) Steroid hormone action in musculoskeletal cells involves membrane receptor and nuclear receptor mechanisms. Connective Tissue Research 44, Suppl. 1, 130-135.
9. Boyan BD, Sylvia VL, Dean DD, Pedrozo H, Del Toro F, Nemere I, Posner GH & Schwartz Z (1999) 1,25-(OH)2D3 modulates growth plate chondrocytes via membrane receptor-mediated protein kinase C by a mechanism that involves changes in phospholipid metabolism and the action of arachidonic acid and PGE2. Steroids 64, 129-136.
10. Bronner F, Pansu D & Stein WD (1986) An analysis of intestinal calcium transport across the rat intestine. American Journal of Physiology 250, G561-G569.
11. Brumbaugh PF & Haussler MR (1973) 1Alpha, 25-dihydroxyvitamin D3 receptor: competitive binding of vitamin D analogs. Life Sciences 13, 1737-1746.
12. Buitrago C, Boland R & de Boland AR (2001a) The tyrosine kinase c-Src is required for 1,25(OH)2-vitamin D3 signalling to the nucleus in muscle cells. Biochimica et Biophysica Acta 1541, 179-187.
13. Buitrago C, Vazquez G, de Boland AR & Boland R (2001b) The vitamin D receptor mediates rapid changes in muscle protein tyrosine phosphorylation induced by 1,25(OH)(2)D(3). Biochemical and Biophysical Research Communications 289, 1150-1156.
14. Buitrago C, Vazquez G, de Boland AR & Boland RL (2000) Activation of Src kinase in skeletal muscle cells by 1, 1,25-(OH(2))-vitamin D(3) correlates with tyrosine phosphorylation of the vitamin D receptor (VDR) and VDR-Src interaction. Journal of Cellular Biochemistry 79, 274-281.
15. Chapuy MC, Preziosi P, Maamer M, Arnaud S, Galan P, Hercberg S & Meunier PJ (1997) Prevalence of vitamin D insufficiency in an adult normal population. Osteoporosis International 7, 439-443.
16. Chen H, Lin RJ, Xie W, Wilpitz D & Evans RM (1999) Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase. Cell 98, 675-686.
17. Chiba N, Suldan Z, Freedman L & Parvin J (2000) Binding of liganded vitamin D receptor to the vitamin D receptor interacting protein coactivator complex induces interaction with RNA polymerase II holoenzyme. Journal of Biological Chemistry 275, 10719-10722.
18. Dawson-Hughes B, Harris S, Kramich C, Dallal G & Rasmussen HM (1993) Calcium retention and hormone levels in black and white women on high- and low-calcium diets. Journal of Bone and Mineral Research 8, 779-787.
19. Demay MB, Kiernan MS, DeLuca HF & Kronenberg HM (1992) Sequences in the human parathyroid hormone gene that bind the 1,25-dihydroxyvitamin D3 receptor and mediate transcriptional repression in response to 1,25-dihydroxyvitamin D3. Proceedings of the National Academy of Sciences USA 89, 8097-8101.
20. Desai RK, van Wijnen AJ, Stein JL, Stein GL & Lian JB (1995) Control of 1,25-dihydroxyvitamin D3 receptor-mediated enhancement of osteoclacin gene transcription: effects of perturbing phosphorylation pathways by okadaic acid and staurosporine. Endocrinology 136, 5685-5693.
21. Devine A, Wilson SG, Dick IM & Prince RL (2002) Effects of vitamin D metabolites on intestinal calcium absorption and bone turnover in elderly women. American Journal of Clinical Nutrition 75, 283-288.
22. Dusso A, Lopez-Hilker S, Rapp N & Slatopolsky E (1988) Extrarenal production of calcitriol in chronic renal failure. Kidney International 34, 368-375.
23. Dwivedi PP, Hii CS, Ferrante A, Tan J, Der CJ, Omdahl JL, Morris HA & May BK (2002) Role of MAP kinases in the 1,25-dihydroxyvitamin D3-induced transactivation of the rat cytochrome P450C24 (CYP24) promoter. Specific functions for ERK1/ERK2 and ERK5. Journal of Biological Chemistry 277, 29643-29653.
24. Erben RG, Soegiarto DW, Weber K, Zeitz U, Lieberherr M, Gniadecki R, Moller G, Adamski J & Balling R (2002) Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin D. Molecular Endocrinology 16, 1524-1537.
25. Farach-Carson MC & Nemere I (2003) Membrane receptors for vitamin D steroid hormones: potential new drug targets. Current Drug Targets 4, 67-76.
26. Freedman LP (1999) Increasing the complexity of coactivation in nuclear receptor signaling. Cell 97, 5-8.
27. Glorieux FH & St-Arnaud R (1997) Vitamin D Pseudodeficiency. In Vitamin D, pp. 755-764 [DD Feldman, FH Gloriex and JW Pike, editors]. San Diego, CA: Academic Press.
28. Haddad JG Jr & Rojanasathit S (1976) Acute administration of 25-hydroxycholecalciferol in man. Journal of Clinical Endocrinology and Metabolism 42, 284-290.
29. Hanchette CL & Schwartz GG (1992) Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation. Cancer 70, 2861-2869.
30. Kara H, Yasunami Y & Adachi T (2002) Alteration of cellular phosphorylation state affects vitamin D receptor-mediated CYP3A4 mRNA induction in Caco-2 cells. Biochemical and Biophysical Research Communications 296, 182-188.
31. Harvey BJ, Alzamora R, Healy V, Renard C & Doolan CM (2002) Rapid responses to steroid hormones: from frog skin to human colon. A homage to Hans Ussing. Biochimica et Biophysica Acta 1566, 116-128.
32. Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH, Dominguez CE & Jurutka PW (1998) The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. Journal of Bone and Mineral Research 13, 325-349.
33. Heaney RP, Barger-Lux MJ, Dowell MS, Chen TC & Holick MF (1997) Calcium absorptive effects of vitamin D and its major metabolites. Journal of Clinical Endocrinology and Metabolism 82, 4111-4116.
34. Heaney RP, Dowell MS, Hale CA & Bendich A (2003) Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. Journal of the American College of Nutrition 22, 142-146.
35. Hedlund TE, Moffatt KA & Miller GJ (1996a) Stable expression of the nuclear vitamin D receptor in the human prostatic carcinoma cell line JCA-1: evidence that the antiproliferative effects of 1 alpha, 25-dihydroxyvitamin D3 are mediated exclusively through the genomic signaling pathway. Endocrinology 137, 1554-1561.
36. Hedlund TE, Moffatt KA & Miller GJ (1996b) Vitamin D receptor expression is required for growth modulation by 1 alpha,25-dihydroxyvitamin D3 in the human prostatic carcinoma cell line ALVA-31. Journal of Steroid Biochemistry and Molecular Biology 58, 277-288.
37. Holick M (1997) Photobiology of vitamin D. In Vitamin D, pp. 33-39 [D Feldman, F Glorieux and J Pike, editors]. San Diego, CA: Academic Press.
38. Holick MF (2003) Vitamin D: A millennium perspective. Journal of Cellular Biochemistry 88, 296-307.
39. Hsu JY, Feldman D, McNeal JE & Peehl DM (2001) Reduced 1alpha-hydroxylase activity in human prostate cancer cells correlates with decreased susceptibility to 25-hydroxyvitamin D3-induced growth inhibition. Cancer Research 61, 2852-2856.
40. Jongen MJ, van der Vijgh WJ, Lips P & Netelenbos JC (1984) Measurement of vitamin D metabolites in anephric subjects. Nephron 36, 230-234.
41. 3 in rat intestinal epithelial cells. Journal of Cellular Biochemistry 55, 230-240.
42. Lee KC, Li J, Cole PA, Wong J & Kraus WL (2003) Transcriptional activation by thyroid hormone receptor-beta involves chromatin remodeling, histone acetylation, and synergistic stimulation by p300 and steroid receptor coactivators. Molecular Endocrinology 17, 908-922.
43. MacLaughlin JA, Anderson RR & Holick MF (1982) Spectral character of sunlight modulates photosynthesis of previtamin D3 and its photoisomers in human skin. Science 216, 1001-1003.
44. Mason RS, Lissner D, Posen S & Norman AW (1980) Blood concentrations of dihydroxylated vitamin D metabolites after an oral dose. British Medical Journal 280, 449-450.
45. Miller GJ, Stapleton GE, Hedlund TE & Moffat KA (1995) Vitamin D receptor expression, 24-hydroxylase activity, and inhibition of growth by 1 alpha, 25-dihydroxyvitamin D3 in seven human prostatic carcinoma cell lines. Clinical Cancer Research 1, 997-1003.
46. Nemere I & Farach-Carson MC (1998) Membrane receptors for steroid hormones: a case for specific cell surface binding sites for vitamin D metabolites and estrogens. Biochemical and Biophysical Research Communications 248, 443-449.
47. Paredes R, Gutierrez J, Gutierrez S, Allison L, Puchi M, Imschenetzky M, van Wijnen A, Lian J, Stein G, Stein J & Montecino M (2002) Interaction of the 1alpha,25-dihydroxyvitamin D3 receptor at the distal promoter region of the bone-specific osteocalcin gene requires nucleosomal remodelling. Biochemical Journal 363, 667-676.
48. Rachez C, Lemon BD, Suldan Z, Bromleigh V, Gamble M, Naar AM, Erdjument-Bromage H, Tempst P & Freedman LP (1999) Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature 398, 824-828.
49. Rowan BG, Weigel NL & O'Malley BW (2000) Phosphorylation of steroid receptor coactivator-1. Identification of the phosphorylation sites and phosphorylation through the mitogen-activated protein kinase pathway. Journal of Biological Chemistry 275, 4475-4483.
50. Schwartz GG & Hulka BS (1990) Is vitamin D deficiency a risk factor for prostate cancer? (hypothesis). Anticancer Research 10, 1307-1311.
51. Schwartz Z, Brooks B, Swain L, Deltoro F, Norman A & Boyan B (1992) Production of 1,25-dihydroxyvitamin-D3 and 24,25-dihydroxyvitamin-D3 by growth zone and resting zone chondrocytes is dependent on cell maturation and is regulated by hormones and growth factors. Endocrinology 130, 2495-2504.
52. Sitrin MD, Bissonnette M, Bolt MJ, Wali R, Khare S, Scaglione-Sewell B, Skarosi S & Brasitus TA (1999) Rapid effects of 1,25(OH)2 vitamin D3 on signal transduction systems in colonic cells. Steroids 64, 137-142.
53. Song Y, Kato S & Fleet JC (2003a) Vitamin D receptor (VDR) knockout mice reveal VDR-independent regulation of intestinal calcium absorption and ECaC2 and calbindin D(9k) mRNA. Journal of Nutrition 133, 374-380.
54. Song Y, Peng X, Porta A, Takanaga H, Peng JB, Hediger MA, Fleet JC & Christakos S (2003b) Calcium transporter 1 and epithelial calcium channel messenger ribonucleic acid are differentially regulated by 1,25 dihydroxyvitamin D3 in the intestine and kidney of mice. Endocrinology 144, 3885-3894.
55. St Arnaud R, Dardenne O, Prud'homme J, Hacking SA & Glorieux FH (2003) Conventional and tissue-specific inactivation of the 25-hydroxy vitamin D-1alpha-hydroxylase (CYP27B1). Journal of Cellular Biochemistry 88, 245-251.
56. Thomas MK, Lloyd-Jones DM, Thadhani RI, Shaw AC, Deraska DJ, Kitch BT, Vamvakas EC, Dick IM, Prince RL & Finkelstein JS (1998) Hypovitaminosis D in medical inpatients. New England Journal of Medicine 338, 777-783.
57. Trivedi DP, Doll R & Khaw KT (2003) Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. British Medical Journal 326, 469.
58. van Cromphaut SJ, Dewerchin M, Hoenderop JG, Stockmans I, Van Herck E, Kato S, Bindels RJ, Collen D, Carmeliet P, Bouillon R & Carmeliet G (2001) Duodenal calcium absorption in vitamin D receptor-knockout mice: functional and molecular aspects. Proceedings of the National Academy of Sciences USA 98, 13324-13329.
59. Wali RK, Kong J, Sitrin MD, Bissonnette M & Li YC (2003) Vitamin D receptor is not required for the rapid actions of 1,25-dihydroxyvitamin D3 to increase intracellular calcium and activate protein kinase C in mouse osteoblasts. Journal of Cellular Biochemistry 88, 794-801.
60. Whitlatch LW, Young MV, Schwartz GG, Flanagan JN, Burnstein KL, Lokeshwar BL, Rich ES, Holick MF & Chen TC (2002) 25-Hydroxyvitamin D-1alpha-hydroxylase activity is diminished in human prostate cancer cells and is enhanced by gene transfer. Journal of Steroid Biochemistry and Molecular Biology 81, 135-140.
61. Zehnder D, Bland R, Williams MC, McNinch RW, Howie AJ, Stewart PM & Hewison M (2001) Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. Journal of Clinical Endocrinology and Metabolism 86, 888-894.
62. Zhuang SH, Schwartz GG, Cameron D & Burnstein KL (1997) Vitamin D receptor content and transcriptional activity do not fully predict antiproliferative effects of vitamin D in human prostate cancer cell lines. Molecular and Cellular Endocrinology 126, 83-90.